Bone Biologics Corp — Director's Dealing 2015

Dec 31, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (NONE)
CIK: 0001419554
Period of Report: 2015-12-28

Reporting Person: Treat William Jay (Chief Technology Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-28	Employee Stock Option (Right to Buy)	$1.59	A	799414	Acquired	2025-12-27	Common Stock (799414)	Direct

Footnotes

F1: 532,942 shares subject to the option are immediately exercisable and the remaining shares subject to the option shall vest and become exercisable on September 19, 2016, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2015 Equity Incentive Plan) on such vesting date.